Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
German Court Rejects Bid To Force BMW and Mercedes-Benz To Stop Selling New Combustion-Engine Cars After 2030- Flu is rising rapidly, driven by a new variant. Here's what to know
- American tourists left stranded in the Caribbean following flight cancellations after airspace closed for Maduro operation
- We may have less control over how long we live than previously thought
- This widow influencer is using jokes to cope after her husband's death. It's OK if people don't get it.
- How stripping diversity, equity and inclusion from health care may make Americans sicker
- Rediscovering Experience Through Excursions: Individual Travel Stories
- Vote In favor of Your Favored Treat
- Over 1,800 killed since junta seized power in Burkina Faso, rights group says
